<DOC>
	<DOCNO>NCT02540967</DOCNO>
	<brief_summary>The objective study investigate safety effectiveness Gadovist .</brief_summary>
	<brief_title>Drug Use Investigation Gadovist .</brief_title>
	<detailed_description>This prospective , non-interventional , continuous submission safety study include patient plan Gadolinium ( Gd ) contrast enhance Magnetic Resonance Imaging ( MRI ) accordance approve label . The investigator make choice Gd enhance MRI ( decision use Gadovist accord Japanese Package Insert prior enrol patient study ) . The study period 3 year . Data analysis period 1 year . In total , 3300 patient recruit . For patient , data collect defined case report form ( CRF ) visit MRI examination ( per investigator routine practice ) .</detailed_description>
	<criteria>Patients perform contrast enhance Magnetic Resonance Imaging ( MRI ) Gadovist . Patients contraindicate base approved label .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Contrast enhancement follow MR image</keyword>
	<keyword>Brain spine</keyword>
	<keyword>Body extremity</keyword>
	<keyword>Gadobutrol</keyword>
</DOC>